PRKAA2 and diabetes mellitus: Metformin can inhibit the NLRP3 inflammasome activation in apolipoprotein E (apoE) -/- mice and inhibit diabetes-accelerated AS, at least in part by activating AMPK and regulating thioredoxin-1/thioredoxin interacting protein (70).